We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare Down 60.6% YTD: Should You Buy the Dip?
Read MoreHide Full Article
Tenet Healthcare Inc. (THC - Free Report) stock is under pressure due to the coronavirus outbreak which requires hospitals to keep their elective procedures on hold to accommodate any potential surge in admissions.
The U.S. Centers for Disease Control (CDC) and Prevention has recommended that hospital elective procedures, surgeries and non-urgent outpatient visits be postponed once the virus has started to spread through a community.
If coronavirus cases continue to rise, hospitals might experience a surge in admissions, diagnostic requests, drug prescriptions and increased need for ICU capacity and staffing.
However, cancellation in elective surgeries to accommodate coronavirus-infected patients will hurt the company’s revenues, which is already highly leveraged. Notably, Community Health Systems is the most levered of the public hospitals with a 2019 net Debt/EBITDA of 8.1x compared with 5.7x for Tenet Healthcare and 3.4x for HCA Healthcare, Inc. (HCA - Free Report) .
Moreover, it is feared that coronavirus outbreak may cause recession. Such an economic situation may lead to loss of jobs, which would mean less number of people covered by private insurance and more number of people with insurance from Government health schemes – Medicare and Medicaid. Since profitability of the Government sponsored health insurance plans is lower than that covered under employer sponsored plans, margins of the hospitals are likely to take a hit. Higher number of individuals without sufficient health insurance cover might also lead to hospitals facing the issue of bad debts from unpaid medical bills.
Year to date, shares of Tenet Healthcare have lost 60.6% compared with the industry’s decline of 31%.
This decline in share price presents a good buying opportunity for investors. The stock carries a Zacks Rank #2 (Buy) and has an impressive Value Score of A. Our research shows that stocks with a Value Style Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 offer the best opportunities in the value investing space.You can see the complete list of today’s Zacks #1 Rank stocks here.
Tenet Healthcare’s strategic divestitures have helped to streamline its business by focusing on core operations and debt repayment. Its spin-off of Conifer business, expected to close by the end of 2021, is likely to further reduce its debt burden. Accretive acquisitions are significantly strengthening its top line. Its cost-reduction program is likely to favor earnings.
Year to date, other companies in the same space such as Community Health Systems, Inc. (CYH - Free Report) , United Health Services, Inc. (UHS - Free Report) and HCA Healthcare have lost 12.4%, 43.1% and 42.9%, respectively.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Tenet Healthcare Down 60.6% YTD: Should You Buy the Dip?
Tenet Healthcare Inc. (THC - Free Report) stock is under pressure due to the coronavirus outbreak which requires hospitals to keep their elective procedures on hold to accommodate any potential surge in admissions.
The U.S. Centers for Disease Control (CDC) and Prevention has recommended that hospital elective procedures, surgeries and non-urgent outpatient visits be postponed once the virus has started to spread through a community.
If coronavirus cases continue to rise, hospitals might experience a surge in admissions, diagnostic requests, drug prescriptions and increased need for ICU capacity and staffing.
However, cancellation in elective surgeries to accommodate coronavirus-infected patients will hurt the company’s revenues, which is already highly leveraged. Notably, Community Health Systems is the most levered of the public hospitals with a 2019 net Debt/EBITDA of 8.1x compared with 5.7x for Tenet Healthcare and 3.4x for HCA Healthcare, Inc. (HCA - Free Report) .
Moreover, it is feared that coronavirus outbreak may cause recession. Such an economic situation may lead to loss of jobs, which would mean less number of people covered by private insurance and more number of people with insurance from Government health schemes – Medicare and Medicaid. Since profitability of the Government sponsored health insurance plans is lower than that covered under employer sponsored plans, margins of the hospitals are likely to take a hit. Higher number of individuals without sufficient health insurance cover might also lead to hospitals facing the issue of bad debts from unpaid medical bills.
Year to date, shares of Tenet Healthcare have lost 60.6% compared with the industry’s decline of 31%.
This decline in share price presents a good buying opportunity for investors. The stock carries a Zacks Rank #2 (Buy) and has an impressive Value Score of A. Our research shows that stocks with a Value Style Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 offer the best opportunities in the value investing space.You can see the complete list of today’s Zacks #1 Rank stocks here.
Tenet Healthcare’s strategic divestitures have helped to streamline its business by focusing on core operations and debt repayment. Its spin-off of Conifer business, expected to close by the end of 2021, is likely to further reduce its debt burden. Accretive acquisitions are significantly strengthening its top line. Its cost-reduction program is likely to favor earnings.
Year to date, other companies in the same space such as Community Health Systems, Inc. (CYH - Free Report) , United Health Services, Inc. (UHS - Free Report) and HCA Healthcare have lost 12.4%, 43.1% and 42.9%, respectively.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>